Risk of Immune-Related Pneumonitis with PD-1/PD-L1 Inhibitors in Different Cancer Types and Treatment Regimens: A Systematic Review and Meta-Analysis of 22 Randomized Controlled Trials

Han, L; Li, GX; Li, HH; Zhao, L

Han, L (通讯作者),Capital Med Univ, Daxing Hosp, Dept Oncol, Beijing, Peoples R China.

CHEMOTHERAPY, 2023; 68 (1): 1

Abstract

Background: Pneumonitis, the specific toxicity associated with PD-1/PD-L1 inhibitors, is severe and potentially life threatening, and its incidence an......

Full Text Link